KaloBios Strips Ex-CEO Shkreli Of Shareholder Power
KaloBios Pharmaceuticals Inc. is scaling back the shareholder rights of former CEO Martin Shkreli amid its Chapter 11 bankruptcy reorganization plan, the drug development company said Thursday announcing a new agreement...To view the full article, register now.
Already a subscriber? Click here to view full article